Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
City of Hope Medical Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
Goethe University
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
City of Hope Medical Center
Dana-Farber Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
University Hospital Schleswig-Holstein
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
M.D. Anderson Cancer Center
St. Anna Kinderkrebsforschung
University of Nebraska
University of Nebraska
Therapeutic Advances in Childhood Leukemia Consortium
Emory University
Goethe University
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
St. Jude Children's Research Hospital
Goethe University
Goethe University
University of Washington
St. Jude Children's Research Hospital
University of California, San Diego
Therapeutic Advances in Childhood Leukemia Consortium
Roswell Park Cancer Institute
Universität des Saarlandes
Roswell Park Cancer Institute
Lund University Hospital
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
Medical College of Wisconsin
University of Maryland, Baltimore
University of Maryland, Baltimore
Milton S. Hershey Medical Center
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
Gruppo Italiano Malattie EMatologiche dell'Adulto